about
Concordance of non-invasive mechanical and serum tests for liver fibrosis evaluation in chronic hepatitis CImmune thrombocytopenic purpura induced by intestinal tuberculosis in a liver transplant recipient.Primitive reflexes and cognitive function.S-Nitroso-N-acetylcysteine induces de-differentiation of activated hepatic stellate cells and promotes antifibrotic effects in vitro.Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model.Protease inhibitor resistance mutations in untreated Brazilian patients infected with HCV: novel insights about targeted genotyping approaches.S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis.Peginterferon still has a place in the treatment of hepatitis C caused by genotype 3 virus.[Validation of the Brazilian version of mini-test CASI-S].Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot studyHand-foot syndrome due to hepatitis C therapyGluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver diseaseMultiple hepatic metastases of cardiac angiosarcomaDiarrhea: a missed D in the 4D glucagonoma syndromeValidation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed populationLysosomal Acid Lipase Deficiency Leading to Liver Cirrhosis: a Case Report of a Rare Variant MutationEvolution of diagnostic criteria for acute kidney injury in patients with decompensated cirrhosis: A prospective study in a tertiary university hospitalHAV and HBV seroprevalence in 1,000 patients with chronic HCV infection in a Tertiary Care Center in São Paulo, Brazil
P50
Q30360178-7CE1133A-A9EB-4573-B31F-572641208E8AQ33416361-F76AD7BE-D70F-4B7D-B6F8-61E739E74693Q34452259-B38FF491-B2BD-4DDB-815C-CAAD32DD737EQ39494489-8D393752-9B8D-42C8-A3DC-46FAB42B9D54Q41152963-AF1CC308-4FF6-447C-9B27-D5CD4A1BAE01Q42205040-E40AB754-9255-4E4F-B345-74BAA6F9F9EDQ43105330-B095F22A-435D-4DE4-A480-C971961C5195Q44666957-1FB9DD43-7891-4FAD-954D-EF2FA7672927Q53271307-25626602-3B5F-466A-8FFF-D531149E3A87Q57121301-871AC4BC-D56F-4474-B48A-69DE6E70FC36Q57301401-DCF11985-50DF-49F3-B7AF-0F5923953046Q85000512-CE86AC92-1735-4DFE-B15B-9C3790E968BFQ91670245-6C440953-F016-4871-A6C6-17D4DD5BAECCQ91740975-F06B8832-EACE-41A4-9C1E-642B7064E8C4Q91760045-96B1727F-F69B-43D9-BB7F-5555DA575889Q92196436-F16314CE-9D35-4C12-A040-6238929B0000Q92707170-B873B3E4-40EC-40DE-9E88-B290284BD8F8Q95492314-F904737D-5935-400E-B156-12611B12FE16
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Daniel Mazo
@ast
Daniel Mazo
@en
Daniel Mazo
@es
Daniel Mazo
@nl
type
label
Daniel Mazo
@ast
Daniel Mazo
@en
Daniel Mazo
@es
Daniel Mazo
@nl
prefLabel
Daniel Mazo
@ast
Daniel Mazo
@en
Daniel Mazo
@es
Daniel Mazo
@nl
P106
P1153
36899832000
P21
P31
P496
0000-0002-2164-2630